OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects
Samira Mahmoudi, Mehrdad Mohammadpour Dehkordi, Mohammad Hossein Asgarshamsi
Biophysical Chemistry (2022) Vol. 288, pp. 106824-106824
Open Access | Times Cited: 7
Samira Mahmoudi, Mehrdad Mohammadpour Dehkordi, Mohammad Hossein Asgarshamsi
Biophysical Chemistry (2022) Vol. 288, pp. 106824-106824
Open Access | Times Cited: 7
Showing 7 citing articles:
Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 MPro and PLPro
Hossein Mousavi, Behzad Zeynizadeh, Mehdi Rimaz
Bioorganic Chemistry (2023) Vol. 135, pp. 106390-106390
Open Access | Times Cited: 26
Hossein Mousavi, Behzad Zeynizadeh, Mehdi Rimaz
Bioorganic Chemistry (2023) Vol. 135, pp. 106390-106390
Open Access | Times Cited: 26
Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2
Mohamed S. Bekheit, Siva S. Panda, Adel S. Girgis
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115292-115292
Open Access | Times Cited: 26
Mohamed S. Bekheit, Siva S. Panda, Adel S. Girgis
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115292-115292
Open Access | Times Cited: 26
Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15518-15518
Open Access | Times Cited: 7
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15518-15518
Open Access | Times Cited: 7
Molecular Docking Studies of Boron‐Containing Compounds as Dual Inhibitors of SARS‐Cov‐2 Spike Receptor Binding Domain/ACE2 Complex and Main Protease and ADMET Investigations
Selami Ercan, Meryem Pir
ChemistrySelect (2023) Vol. 8, Iss. 47
Closed Access | Times Cited: 2
Selami Ercan, Meryem Pir
ChemistrySelect (2023) Vol. 8, Iss. 47
Closed Access | Times Cited: 2
Synthesis and Crystal Structural Analysis of bismuth phosphovanadate compounds: An Eco-Friendly and Recyclable Catalyst for Green Synthesis of Imidazole Derivatives
Soumya Ferraa, Youssef Merroun, Hanane Barebita, et al.
Journal of the Indian Chemical Society (2024) Vol. 101, Iss. 10, pp. 101313-101313
Closed Access
Soumya Ferraa, Youssef Merroun, Hanane Barebita, et al.
Journal of the Indian Chemical Society (2024) Vol. 101, Iss. 10, pp. 101313-101313
Closed Access
Development of a database of RNA helicase inhibitors (VHIMDB) of pathogenic viruses and in silico screening for the potential drug molecules
Raghunath Satpathy, Sarat Kumar Acharya
The EuroBiotech Journal (2022) Vol. 6, Iss. 3, pp. 116-125
Open Access | Times Cited: 2
Raghunath Satpathy, Sarat Kumar Acharya
The EuroBiotech Journal (2022) Vol. 6, Iss. 3, pp. 116-125
Open Access | Times Cited: 2
Evaluation of in vitro SARS‐CoV‐2 inactivation by a new quaternary ammonium compound: Bromiphen bromide
Sergio Strizzi, Gioia Cappelletti, Mara Biasin, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Open Access
Sergio Strizzi, Gioia Cappelletti, Mara Biasin, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Open Access
